Our data reveal that C3G promoted melanoma cell apoptosis both in vitro and in vivo by binding to the ERβ, which, in turn, inhibited the expression of CCNB1 and triggered the apoptosis pathway. The gene discussed is ESR2; the disease is melanoma.